-
Keeping Blood Sugar Steady Helps You Live Longer With Diabetes
drugs
September 20, 2019
Keeping your blood sugar levels stable over time may be key to living longer if you have type 2 diabetes.
-
Rates of Diabetes Higher at Lower BMIs Among Minorities
drugs
September 20, 2019
According to a study published online Sept. 19 in Diabetes Care, even at lower body weights, members of certain racial and ethnic-minority groups have a higher prevalence of diabetes or prediabetes than whites.
-
Diabetes Distress Common at Large Midwestern University
drugs
September 19, 2019
According to a study published in the September issue of the Journal of the American Osteopathic Association, in a large university population, the prevalence of diabetes distress is high ...
-
Greater Height Linked to Lower Risk for Type 2 Diabetes
drugs
September 12, 2019
Greater height is associated with a lower risk for type 2 diabetes, according to a study published online in Diabetologia.
-
T2DM Risk Reduced by 75 Percent With Healthiest Lifestyle
drugs
September 10, 2019
Individuals with the healthiest lifestyle have a 75 percent reduced risk for type 2 diabetes, and those with diabetes have a lower risk for mortality, according to a review published online in Diabetologia.
-
Diabetes Control Has Stalled Across U.S.
drugs
September 09, 2019
U.S. adults with diabetes are no more likely to meet disease control targets than they were in 2005, a new study finds.
-
ESC Guidelines Updated for Managing CVD in Diabetes
drugs
September 06, 2019
In updated guidelines developed by the European Society of Cardiology, in collaboration with the European Association for the Study of Diabetes...
-
Dipeptidyl Peptidase-4 Inhibitors May Up Pancreatic Disease Risk
drugs
August 29, 2019
Use of dipeptidyl peptidase-4 inhibitors (DPP-4i) is associated with increased risks for pancreatitis and pancreatic cancer in patients with newly diagnosed type 2 diabetes...
-
Polyunsaturated Fatty Acids Have Little, No Impact on Diabetes
drugs
August 28, 2019
Polyunsaturated fatty acids (PUFA) have little to no effect on the prevention or treatment of type 2 diabetes mellitus, according to a review published online in The BMJ.
-
Liraglutide Ups Risk for Gallbladder, Biliary Tract Events
drugs
August 27, 2019
There is an increased risk for gallbladder- or biliary tract-related events among patients with type 2 diabetes taking liraglutide versus placebo, according to a study published online in Diabetes Care.